Opportunistic viral Infections Flashcards

1
Q

What are endogenous and exogenous viruses?

A
  • ‘Endogenous’
    Latent viruses that reactivate in absence of immune system
    Acquired in past prior to immune suppression e.g. Varicella Zoster
  • ‘Exogenous’
    Viruses acquired from environment
    increased severity in immunosuppressed e.g. Influenza, SARS-CoV-2
  • Symptomatology may be altered vs. healthy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the AIDS defining illness: viral causes?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the Baltimore classification

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do we detect viruses?

A

•Viruses are challenging to grow- requiring human cells & dangerous

  • Therefore we look for indirect or direct evidence of their presence
  • Indirect detection: response of the immune system to the virus•
  • These tests are useful to see if you have ever had the infection
  • Direct detection: fragments of the actual virus
  • Viral proteins (lateral flow/antigen tests)
  • Viral genetic material (the virus genetic material present with patient sample•Polymerase chain reaction
  • These tests are useful to see if you have the infection now
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe serology.

A
  • Measure levels of antibody in patients serum•
  • +++ IgM indicate Active or Resolving infection
  • +++ IgG indicates past infection > 6 weeks ago
  • •Antibody levels ↓↓↓ reduced in Immunosuppressed• - may lose antibodies
  • Serological course may differ depending upon virus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the use of PCRs

A
  • Polymerase chain reaction•
  • Detect viral genome in samples via amplification•
  • Highly sensitive and specific•
  • Performed on many different sample types•
  • Viral load can be used to monitor infection•
  • May remain positive after infection resolved
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the diagnostic test we use when immunocompromised

A

•Immune system = non functional → Serology - cant be done

1.Screen prior to immunosuppression

  • Identify previous viral exposure that may reactivate
  • Guide the use of antiviral prophylaxis•

2.Monitor using PCR

  • Identify viral reactivation promptly → Rx
  • Detect infection
  • Approach is performed by protocol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the diagnostic protocols in immunosuppressed?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
A

HEV PCR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the relative risk of opportunistic viral infection?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the transplant immunosuppression timeline?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the sources of viral infections in transplant recipients?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
A

Allogeneic Stem cell transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What infections do we screen for with molecular testing?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the features of anti-viral therapy in the immunosuppressed?

A
  • Therapeutically challenging
  • Pre-emptive treatment
  • Prophylaxis
  • Increased doses
  • Longer duration
  • Combination therapy
  • ↑ Opportunity antiviral resistance
  • ↑ Toxicity of antivirals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How are viral infections different in the immunocompromised?

A
  • Present differently
  • Disseminated
  • Different organs
  • More severe
  • Oncogenic
  • Lack of immune mediated symptoms
17
Q

What are the issues with HSV 1 & 2 infection and how do we manage them in the immunocompromised?

A
18
Q

What does VZV cause in immunosuppresed?

A
19
Q

How do we prevent and manage VZV infections?

A
20
Q
A

HSV PCR

21
Q

What does post-transplant lymphoproliferative disease (PTLD) predispose to? How can we confirm it?

A
22
Q

What are the issues and management of EBV infections in immunosupression?

A
23
Q

What are the issues and management of CMV in the immunosuppressed?

A
24
Q

What are the manifestations of CMV infection?

A
25
Q

How does CMV infection differ between solid organ transplants and haemotopoietic stem cell transplant?

A
26
Q

What are the CMV prevention strategies post-transplant?

A
27
Q

What is CMV treatment?

A
28
Q
A

Rituximab - anti B cell mAb

29
Q

What is the John Cunningham virus? What does it cause? Who do we see it in?

A
30
Q

Describe progressive multifocal leukoencephalopathy. How do we diagnose it?

A
31
Q

What is BK virus?

A
32
Q

What respiratory viruses do we see in the immunocompromised?

A
33
Q

Which of the Hepatitis viruses do we worry about?

A
34
Q

What can happen in hepatitis B infections in the immunocompromised? How do we prevent them?

A
35
Q

What are the markers of disease and immunity in Hep B ?

A
36
Q

Describe the risk of HBV reactivation and how we prevent it?

A
37
Q
A

C